Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus carbamazepine for Rolandic seizures in children
IRCT20190208042654N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carbamazepine in Benign Rolandic Epilepsy (BECTS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Seizure frequency, Seizure duration and 2 more. Started Oct 2019; status: completed.
02
Drugs
carbamazepine
03
Conditions
Benign Rolandic Epilepsy (BECTS)
Beyond the preview
Go deeper on IRCT20190208042654N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190208042654N3.